Cargando…
GZD824 suppresses the growth of human B cell precursor acute lymphoblastic leukemia cells by inhibiting the SRC kinase and PI3K/AKT pathways
Available therapeutic options for advanced B cell precursor acute lymphoblastic leukemia (pre-B ALL) are limited. Many lead to neutropenia, leaving patients at risk of life-threatening infections and result in bad outcomes. New treatment options are needed to improve overall survival. We previously...
Autores principales: | Ye, Wei, Jiang, Zhiwu, Lu, Xiaoyun, Ren, Xiaomei, Deng, Manman, Lin, Shouheng, Xiao, Yiren, Lin, Simiao, Wang, Suna, Li, Baiheng, Zheng, Yi, Lai, Peilong, Weng, Jianyu, Wu, Donghai, Ma, Yuguo, Chen, Xudong, Wen, Zhesheng, Chen, Yaoyu, Feng, Xiaoyan, Li, Yangqiu, Liu, Pentao, Du, Xin, Pei, Duanqing, Yao, Yao, Xu, Bing, Ding, Ke, Li, Peng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5675611/ https://www.ncbi.nlm.nih.gov/pubmed/29152059 http://dx.doi.org/10.18632/oncotarget.10881 |
Ejemplares similares
-
Heterogeneity of CD34 and CD38 expression in acute B lymphoblastic leukemia cells is reversible and not hierarchically organized
por: Jiang, Zhiwu, et al.
Publicado: (2016) -
CD215+ Myeloid Cells Respond to Interleukin 15 Stimulation and Promote Tumor Progression
por: Lin, Shouheng, et al.
Publicado: (2017) -
GZD824 overcomes FGFR1‐V561F/M mutant resistance in vitro and in vivo
por: Jiang, Kaili, et al.
Publicado: (2021) -
GZD824 as a FLT3, FGFR1 and PDGFRα Inhibitor Against Leukemia In Vitro and In Vivo
por: Wang, Yuting, et al.
Publicado: (2020) -
Incorporation of a hinge domain improves the expansion of chimeric antigen receptor T cells
por: Qin, Le, et al.
Publicado: (2017)